Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Hematopoietic Stem Cell Transplantation (HSCT): early-phase trial registry

2 of 3 indexed Hematopoietic Stem Cell Transplantation (HSCT) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Hematopoietic Stem Cell Transplantation (HSCT): 3 US clinical trials tracked, 2 recruiting.

Hematopoietic Stem Cell Transplantation (HSCT) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's National Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition hematopoietic-stem-cell-transplantation-hsct

OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Hematopoietic Stem Cell (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Hematopoietic Stem Cell Transplantation (HSCT)

Hematopoietic Stem Cell Transplantation (HSCT) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hematopoietic Stem Cell Transplantation (HSCT) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hematopoietic Stem Cell Transplantation (HSCT) is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Hematopoietic Stem Cell Transplantation (HSCT) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Oral Thin Film (OTF) Cholecalciferol (Vitamin D3) Dietary supplement
1 trials
Norovirus -specific T-cell (NST) therapy Biological
1 trials
Massage therapy Other
1 trials
Standard of care Other
1 trials

US sites by state

Facility locations filed on Hematopoietic Stem Cell Transplantation (HSCT) trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Ohio 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hematopoietic Stem Cell Transplantation (HSCT) page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic Stem Cell Transplantation (HSCT) condition card totals 3 registered trials; most-linked intervention Oral Thin Film (OTF) Cholecalciferol (Vitamin D3); top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.